Get a Deep Insight into the World Artificial Organs Market

Market Wire, March, 2008

Thoratec Obtains FDA approval for Implantable Ventricular Assist Device II-78

FDA Grants Approval to World Heart's Novacor® LVAS for Destination Therapy II-78

MicroMed Technology Receives Approval for DeBakey VAD Child Heart Pump II-79

FDA Awards Orphan Drug Designation for Core Component of Vital Therapies' ELAD II-79

SynCardia Systems Licenses Technology from MEDOS II-79

Asahi to Set Up New Subsidiary II-79

Asahi Medical Renames to Asahi Kasei Medical II-79

MicroMed Technology Announces Implantation of First DeBakey VAD for Destination Therapy II-79

Vital Therapies Takes Over VitaGen Assets II-80

Advanced Biotherapy Inks Agreement with Russian Federation Ministry of Health/State Institute of Transplantation and Artificial Organs II-80

Novalung Signs Agreements with MC3 II-80

Asahi Kasei to Enhance Artificial Kidney Device Production Capacity II-81

Terumo Sells Hemodialyzer Operations to Asahi II-81

Jostra Snaps Up Life Stream International II-81

Excorp Medical's Bioartificial Liver Secures Special Orphan

Drug Status from FDA II-81

MicroMedical Industries Changes Name to Ventracor II-81

Exten Industries Completes Acquisition of MultiCell Associates II-81

Thoratec Laboratories Merges with Thermo Cardiosystems II-82

Baxter Forms Strategic Alliance with Dainippon Ink & Chemicals II-82

Covalent Group Strikes Deal with VitaGen II-82

Renal Plant Inks Pact with Micronics II-82

Abiomed Wins FDA Approval for Artificial Heart Testing II-82

MicroMedical Industries Bags Second US Patent for VentrAssist Artificial Heart Technology II-83

FDA Grants Approval to Commence Clinical Trails in the US for Arrow LionHeart(TM) LVAS II-83

Arrow International Announces First US Implant of LionHeart II-83

University of Louisville Implants First AbioCor Implantable Replacement Heart II-83

Kestrel Equity Partners Releases Second Phase of Funding II-84

MultiCell Associates Changes Name to MultiCell Technologies II-84

Thoratec Laboratories Acquires Thermo CardioSystems II-84

McGowan Center Signs Agreement with HemoMax and Alteon II-84

FDA Grants Approval for Innovative Artificial Kidney System II-85

Minntech Commences Second Dialyzer Reprocessing Center II-85

SMAD Invests in Artificial Kidney Line II-85

US Patent and Trademark Office Grants Patent to MedQuest's Artificial Heart Technology II-85

Kestrel Equity Partners Provides Funds to Exten and Xenogenics II-85

Edwards Lifesciences Divests Novocor Heart Pumps to WorldHeart II-85

10. Focus on Select Global Players II-86

Abbott Laboratories (USA) II-86

Abiomed Inc (USA) II-86

Arbios Systems, Inc. (USA) II-86

Arrow International, Inc. (USA) II-87

Asahi Kasei Medical Co., Ltd. (Japan) II-87

Baxter International, Inc. (USA) II-87

Bayer AG (Germany) II-88

F. Hoffmann-La Roche Ltd. (Switzerland) II-88

Fresenius Medical Care AG & Co. KGaA (Germany) II-89

Fresenius Medical Care Holdings (USA) II-89

Fresenius Kawasumi (Japan) II-89

Fresenius Medical Care Japan K.K. (Japan) II-89

Renal Care Group (USA) II-89

Gambro AB (Sweden) II-90

Gish Biomedical, Inc. (USA) II-90

HepaLife Technologies, Inc. (USA) II-90